Avik Ray, M.B.,B.S., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Coronary Syndrome | 3 | 2024 | 2363 | 0.770 |
Why?
|
Munchausen Syndrome | 1 | 2020 | 19 | 0.740 |
Why?
|
Antiviral Agents | 2 | 2022 | 3062 | 0.630 |
Why?
|
Propensity Score | 1 | 2024 | 1917 | 0.540 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 552 | 0.490 |
Why?
|
Probability | 1 | 2020 | 2474 | 0.470 |
Why?
|
Platelet Aggregation Inhibitors | 3 | 2024 | 3193 | 0.470 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3088 | 0.470 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3208 | 0.460 |
Why?
|
Confidence Intervals | 1 | 2020 | 2932 | 0.460 |
Why?
|
Hypoglycemia | 1 | 2020 | 883 | 0.430 |
Why?
|
Data Interpretation, Statistical | 1 | 2020 | 2694 | 0.340 |
Why?
|
Crohn Disease | 1 | 2022 | 2276 | 0.330 |
Why?
|
Pandemics | 5 | 2021 | 8604 | 0.320 |
Why?
|
Psychiatry | 1 | 2020 | 1683 | 0.300 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 7379 | 0.300 |
Why?
|
Biomedical Research | 1 | 2020 | 3414 | 0.230 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 981 | 0.220 |
Why?
|
Incretins | 1 | 2023 | 103 | 0.210 |
Why?
|
Glucagon-Like Peptides | 1 | 2023 | 159 | 0.200 |
Why?
|
Pharmacy Service, Hospital | 1 | 2023 | 135 | 0.200 |
Why?
|
Famotidine | 1 | 2021 | 17 | 0.190 |
Why?
|
Hydroxychloroquine | 2 | 2022 | 428 | 0.180 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2024 | 380 | 0.180 |
Why?
|
Snake Bites | 1 | 2020 | 28 | 0.180 |
Why?
|
Selection Bias | 1 | 2022 | 358 | 0.180 |
Why?
|
Adenosine Monophosphate | 1 | 2022 | 282 | 0.170 |
Why?
|
India | 2 | 2024 | 2344 | 0.170 |
Why?
|
Histamine H2 Antagonists | 1 | 2021 | 167 | 0.170 |
Why?
|
Poverty Areas | 1 | 2021 | 264 | 0.170 |
Why?
|
Hemorrhage | 2 | 2023 | 3606 | 0.170 |
Why?
|
Alanine | 1 | 2022 | 606 | 0.170 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12270 | 0.170 |
Why?
|
Heart Failure | 1 | 2023 | 11832 | 0.160 |
Why?
|
Klebsiella Infections | 1 | 2020 | 147 | 0.160 |
Why?
|
Drug Repositioning | 1 | 2021 | 231 | 0.160 |
Why?
|
Cellulitis | 1 | 2020 | 208 | 0.160 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2024 | 1880 | 0.130 |
Why?
|
World Health Organization | 1 | 2022 | 1317 | 0.130 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10329 | 0.130 |
Why?
|
Uncertainty | 1 | 2020 | 754 | 0.120 |
Why?
|
Organoids | 1 | 2020 | 729 | 0.120 |
Why?
|
Humans | 18 | 2024 | 759098 | 0.110 |
Why?
|
Schools, Medical | 1 | 2020 | 877 | 0.110 |
Why?
|
Treatment Outcome | 4 | 2024 | 64867 | 0.110 |
Why?
|
Teaching | 1 | 2020 | 1161 | 0.110 |
Why?
|
Weight Loss | 1 | 2023 | 2673 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2020 | 1065 | 0.090 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3153 | 0.090 |
Why?
|
Oxygen | 1 | 2022 | 4188 | 0.090 |
Why?
|
Medication Adherence | 1 | 2021 | 2161 | 0.080 |
Why?
|
Internet | 1 | 2020 | 3073 | 0.080 |
Why?
|
Aspirin | 1 | 2020 | 3359 | 0.080 |
Why?
|
Stem Cells | 1 | 2020 | 3523 | 0.070 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7003 | 0.070 |
Why?
|
Pilot Projects | 1 | 2020 | 8530 | 0.070 |
Why?
|
Incidence | 1 | 2024 | 21344 | 0.060 |
Why?
|
Models, Biological | 1 | 2020 | 9460 | 0.060 |
Why?
|
Follow-Up Studies | 1 | 2024 | 39213 | 0.050 |
Why?
|
Medication Therapy Management | 1 | 2023 | 132 | 0.050 |
Why?
|
Receptors, Histamine H2 | 1 | 2021 | 18 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 12896 | 0.050 |
Why?
|
Pharmacology | 1 | 2020 | 99 | 0.040 |
Why?
|
Pharmacists | 1 | 2023 | 259 | 0.040 |
Why?
|
Prospective Studies | 1 | 2023 | 54190 | 0.040 |
Why?
|
Academies and Institutes | 1 | 2020 | 319 | 0.040 |
Why?
|
Middle Aged | 2 | 2024 | 219628 | 0.040 |
Why?
|
Dust | 1 | 2020 | 481 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 919 | 0.030 |
Why?
|
Hospital Costs | 1 | 2023 | 977 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2021 | 1343 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2024 | 80125 | 0.030 |
Why?
|
Male | 2 | 2024 | 358602 | 0.030 |
Why?
|
Prevalence | 1 | 2021 | 15639 | 0.030 |
Why?
|
Virus Replication | 1 | 2021 | 2431 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2020 | 1665 | 0.030 |
Why?
|
Drug Discovery | 1 | 2020 | 1053 | 0.030 |
Why?
|
Animals | 2 | 2020 | 167531 | 0.020 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2062 | 0.020 |
Why?
|
Hospitalization | 1 | 2021 | 10732 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3460 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3929 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1845 | 0.020 |
Why?
|
Adult | 1 | 2022 | 219353 | 0.020 |
Why?
|
Students, Medical | 1 | 2020 | 1921 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9245 | 0.020 |
Why?
|
Cytokines | 1 | 2021 | 7290 | 0.020 |
Why?
|
Female | 1 | 2024 | 390174 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25853 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23328 | 0.010 |
Why?
|
Aged | 1 | 2023 | 168615 | 0.010 |
Why?
|